New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 14, 2013
08:14 EDTMDASMedAssets valuation is exceptionally attractive, says RW Baird
Baird believes the valuation of MedAssets is exceptionally attractive and raised its price target to $25 from $24. The firm cited recent contract wins, expansions, and believes it will hit its above Street Q4 guidance. Shares are Outperform rated.
News For MDAS From The Last 14 Days
Check below for free stories on MDAS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 19, 2014
10:13 EDTMDASOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:09 EDTMDASMedAssets upgraded to Outperform from Market Perform at Leerink
Leerink upgraded MedAssets to Outperform citing the pullback in shares since the Q2 results, the potential for improving volumes in Q3 and the company's total portfolio approach. The firm has a $26 price target for shares.
06:04 EDTMDASMedAssets upgraded to Outperform from Market Perform at Leerink
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use